189 results
Page 7 of 10
6-K
EX-99.1
7cn1tf7
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
75mq5mbtm1klb49pxj
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
wpsegbsawxql9ulq2
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
j6azxcke5xjzde0a9
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.1
hkzomwz5irywrje246i
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.2
ti61ncgt
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
cex0afxm32c0b0yz p1v
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
s6533k55
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am
6-K
EX-99.1
ngp3zouj5sf1r kja23
18 Oct 18
Current report (foreign)
11:03am
6-K
EX-99.1
tfcv5nnoyk
18 Oct 18
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
9:06am
6-K
EX-99.1
u0qw mm1c
17 Oct 18
RepliCel Life Sciences Appoints New Chief Financial Officer
10:58am
6-K
EX-99.1
1130s8eqe74ej rl4t
15 Oct 18
RepliCel CEO Provides Updated Outlook
11:27am
6-K
EX-99.1
fun78ha
11 Oct 18
RepliCel Life Sciences Completes Financing with YOFOTO (China) Health
11:45am
6-K
EX-99.1
6txqt7o
24 Sep 18
RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete Investment
10:48am
6-K
EX-99.2
2wghdhf9uvnrhxnmce
9 Aug 18
Current report (foreign)
12:00am
6-K
EX-99.1
y94hgi4t 0tse25a2r51
9 Aug 18
Current report (foreign)
12:00am
6-K
EX-99.1
5cep8 jqme
11 Jul 18
RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China
12:21pm
6-K
EX-99.1
wfxotct1ny bg
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
pc6kx6n
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am